All In Biotech

Drug Trial Radar · NCT00503698

The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis

Efficacy and Safety of Somatropin in Adult Patients on Chronic Haemodialysis

Last checked: Nov 19, 2026Latest source record: Mar 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 712 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

712

Actual

Start

Jul 2007

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Jul 19, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted in Africa, Asia, Europe, North and South America and Oceania. The aim of the trial is to evaluate the effect of somatropin (human growth hormone) on survival (primary end-point; "time to death" and health related quality of life in adult patients on chronic haemodialysis.

Conditions

  • Chronic Kidney Disease
  • End-Stage Renal Disease

Interventions

  • somatropinDrug

    20 mcg/kg/day, injected s.c. (under the skin)

  • placeboDrug

    Placebo injected s.c (under the skin)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mortality - Time to All-cause DeathTime frame: week 0, trial termination

Locations

381 sites in 21 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Alexander City, Alabama

  • Novo Nordisk Investigational Site

    Birmingham, Alabama

  • Novo Nordisk Investigational Site

    Madison, Alabama

  • Novo Nordisk Investigational Site

    Mobile, Alabama

  • Novo Nordisk Investigational Site

    Mobile, Alabama

  • Novo Nordisk Investigational Site

    Montgomery, Alabama

  • Novo Nordisk Investigational Site

    Glendale, Arizona

  • Novo Nordisk Investigational Site

    Phoenix, Arizona

  • Novo Nordisk Investigational Site

    Tempe, Arizona

  • Novo Nordisk Investigational Site

    Tucson, Arizona

  • Novo Nordisk Investigational Site

    Tuscon, Arizona

  • Novo Nordisk Investigational Site

    El Dorado, Arkansas

  • Novo Nordisk Investigational Site

    Fort Smith, Arkansas

  • Novo Nordisk Investigational Site

    Hot Springs, Arkansas

  • Novo Nordisk Investigational Site

    Little Rock, Arkansas

  • Novo Nordisk Investigational Site

    McGehee, Arkansas

  • Novo Nordisk Investigational Site

    Paragould, Arkansas

  • Novo Nordisk Investigational Site

    Pine Bluff, Arkansas

  • Novo Nordisk Investigational Site

    Beverly Hills, California

  • Novo Nordisk Investigational Site

    Chula Vista, California

  • Novo Nordisk Investigational Site

    Covina, California

  • Novo Nordisk Investigational Site

    Escondido, California

  • Novo Nordisk Investigational Site

    Glendale, California

  • Novo Nordisk Investigational Site

    La Mesa, California

  • Novo Nordisk Investigational Site

    Lakewood, California

  • Novo Nordisk Investigational Site

    Long Beach, California

  • Novo Nordisk Investigational Site

    Los Alamitos, California

  • Novo Nordisk Investigational Site

    Los Angeles, California

  • Novo Nordisk Investigational Site

    Los Angeles, California

  • Novo Nordisk Investigational Site

    Los Angeles, California

  • Novo Nordisk Investigational Site

    Lynwood, California

  • Novo Nordisk Investigational Site

    Merced, California

  • Novo Nordisk Investigational Site

    Mission Hills, California

  • Novo Nordisk Investigational Site

    Monterey Park, California

  • Novo Nordisk Investigational Site

    Mountain View, California

  • Novo Nordisk Investigational Site

    Pasadena, California

  • Novo Nordisk Investigational Site

    Porterville, California

  • Novo Nordisk Investigational Site

    Riverside, California

  • Novo Nordisk Investigational Site

    Sacramento, California

  • Novo Nordisk Investigational Site

    Torrance, California

Showing 40 of 381 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.